153 related articles for article (PubMed ID: 22942707)
21. Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.
Li Z; Guo Z
Pathol Oncol Res; 2020 Apr; 26(2):1057-1062. PubMed ID: 30989488
[TBL] [Abstract][Full Text] [Related]
22. Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.
Guo Q; Wang HB; Li YH; Li HF; Li TT; Zhang WX; Xiang SS; Sun ZQ
Med Sci Monit; 2016 Aug; 22():2816-24. PubMed ID: 27506957
[TBL] [Abstract][Full Text] [Related]
23. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
[TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.
Shargh SA; Sakizli M; Khalaj V; Movafagh A; Yazdi H; Hagigatjou E; Sayad A; Mansouri N; Mortazavi-Tabatabaei SA; Khorram Khorshid HR
Med Oncol; 2014 Nov; 31(11):250. PubMed ID: 25260805
[TBL] [Abstract][Full Text] [Related]
26. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.
Lee EJ; Lee BB; Han J; Cho EY; Shim YM; Park J; Kim DH
Int J Cancer; 2008 Nov; 123(9):2073-9. PubMed ID: 18697202
[TBL] [Abstract][Full Text] [Related]
27. CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.
Yu QM; Wang XB; Luo J; Wang S; Fang XH; Yu JL; Ling ZQ
J Surg Oncol; 2012 Nov; 106(6):765-71. PubMed ID: 22514028
[TBL] [Abstract][Full Text] [Related]
28. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility].
Aristizábal-Pachón AF; Takahashi CS
Biomedica; 2016 Dec; 36(4):593-602. PubMed ID: 27992986
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
[TBL] [Abstract][Full Text] [Related]
30. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.
Sun D; Zhang Z; Van do N; Huang G; Ernberg I; Hu L
Oral Oncol; 2007 Jan; 43(1):82-7. PubMed ID: 16807071
[TBL] [Abstract][Full Text] [Related]
33. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
34. Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer.
Celebiler Cavusoglu A; Kilic Y; Saydam S; Canda T; Başkan Z; Sevinc AI; Sakizli M
Cancer Sci; 2009 Dec; 100(12):2341-5. PubMed ID: 19799609
[TBL] [Abstract][Full Text] [Related]
35. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
Wen G; Wang H; Zhong Z
Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
[TBL] [Abstract][Full Text] [Related]
36. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
[TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer.
Zhong YH; Peng H; Cheng HZ; Wang P
Asian Pac J Cancer Prev; 2015; 16(3):1139-43. PubMed ID: 25735345
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
40. CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma.
Belut DR; Lima EO; Zanini MA; Galvani AF; Furtado FB; Ferrasi AC
Eur J Cancer Prev; 2024 Jan; 33(1):73-btii. PubMed ID: 37401481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
